Bayer Receivables 2010-2024 | BAYRY

Bayer receivables for the quarter ending September 30, 2024 were $15.207B, a 1.98% decline year-over-year.

  • Bayer receivables for 2023 were $13.87B, a 4.21% decline from 2022.
  • Bayer receivables for 2022 were $14.479B, a 7.86% decline from 2021.
  • Bayer receivables for 2021 were $15.714B, a 10.45% increase from 2020.

Bayer Receivables 2010-2024 | BAYRY

  • Bayer receivables for 2023 were $13.87B, a 4.21% decline from 2022.
  • Bayer receivables for 2022 were $14.479B, a 7.86% decline from 2021.
  • Bayer receivables for 2021 were $15.714B, a 10.45% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
Merck (MRK)$251.1B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Innoviva (INVA)$1.1B